ClinicalTrials.gov
public full text
Public Domain
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
The purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound (LIFU) using the Exablate® Model 4000 Type 2.0/2.1 as an adjunctive neuromodulatory treatment for OUD (Opioid Use Disorder) and/or other Substance Use Disorders (SUDs) by assessing its safety and tolerability in subjects with OUD.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)#888644
- Neuromodulation in Substance Use Disorders#1047388
- Neuromodulation Implantation Settings Variation for Overactive Bladder#884133
- First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers#1007087
- To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder#1047722
Record · ID 914813
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive